다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Molecular and cellular biology, v.21 no.1, 2001년, pp.310 - 318
Zhang, Shuling-L. (Laboratory of Genetics) , DuBois, Wendy (Laboratory of Genetics) , Ramsay, Edward S. (Laboratory of Genetics) , Bliskovski, Valeri (Laboratory of Genetics) , Morse III, Herbert C. (Laboratory of Immunopathology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892) , Taddesse-Heath, Leki (Laboratory of Immunopathology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892) , Vass, William C. (Laboratory of Cellular Oncology, Division of Basic Sciences, National Cancer Institute) , DePinho, Ronald A. (Department of Adult Oncology, Dana-Farber Cancer Institute, and Departments of Genetics and Medicine, Harvard Medical School, Boston, Massachusetts 02115) , Mock, Beverly A. (Laboratory of Genetics)
AI-Helper
ABSTRACT The susceptibility of BALB/c mice to pristane-induced plasmacytomas is a complex genetic trait involving multiple loci, while DBA/2 and C57BL/6 strains are genetically resistant to the plasmacytomagenic effects of pristane. In this model system for human B-cell neoplasia, one of the BALB/c ...
Ahmad, N. Nina, Barbosa de Melo, Mônica, Singh, Arun D., Donoso, Larry A., Shields, Jerry A.. A possible hot spot in exon 21 of the retinoblastoma gene predisposing to a low penetrant retinoblastoma phenotype?. Ophthalmic genetics, vol.20, no.4, 225-231.
Bates, Stewart, Phillips, Andrew C., Clark, Paula A., Stott, Francesca, Peters, Gordon, Ludwig, Robert L., Vousden, Karen H.. p14ARF links the tumour suppressors RB and p53. Nature, vol.395, no.6698, 124-125.
Brown, Robert T., Ades, Ibrahim Z., Nordan, Richard P.. An Acute Phase Response Factor/NF-κB Site Downstream of the junB Gene That Mediates Responsiveness to Interleukin-6 in a Murine Plasmacytoma. The Journal of biological chemistry, vol.270, no.52, 31129-31135.
Carter, Angela M., Catto, Andrew J., Grant, Peter J.. Association of the α-Fibrinogen Thr312Ala Polymorphism With Poststroke Mortality in Subjects With Atrial Fibrillation. Circulation, vol.99, no.18, 2423-2426.
Proc. Natl. Acad. Sci. USA Clynes R. J. 6067 85 1988 10.1073/pnas.85.16.6067
Cormier, Robert T., Hong, Karen H., Halberg, Richard B., Hawkins, Trevor L., Richardson, Paul, Mulherkar, Rita, Dove, William F., Lander, Eric S.. Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis. Nature genetics, vol.17, no.1, 88-91.
Dietrich, W.F., Lander, E.S., Smith, J.S., Moser, A.R., Gould, K.A., Luongo, C., Borenstein, N., Dove, W.. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell, vol.75, no.4, 631-639.
Blood Dilworth D. 1869 95 1999 10.1182/blood.V95.5.1869.005k09_1869_1871
Drexler, H G. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia–lymphoma cells. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K, vol.12, no.6, 845-859.
Farker, K., Lehmann, M.H., Kästner, R., Weber, J., Janitzky, V., Schubert, J., Hoffmann, A.. Analysis of point mutation in exon 2 of CYP2E1 gene in renal cell/urothelial cancer patients in comparison with control population. International journal of clinical pharmacology and therapeutics, vol.38, no.1, 30-34.
Mol. Diagn. Ford M. E. 211 4 1999 10.1016/S1084-8592(99)80024-1
Haidar, MA, Cao, XB, Manshouri, T, Chan, LL, Glassman, A, Kantarjian, HM, Keating, MJ, Beran, MS, Albitar, M. p16INK4A and p15INK4B gene deletions in primary leukemias. Blood, vol.86, no.1, 311-315.
Ho, S.N., Hunt, H.D., Horton, R.M., Pullen, J.K., Pease, L.R.. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene, vol.77, no.1, 51-59.
BioTechniques Jiang W. 348 24 1998 10.2144/98243bm03
Kamijo, Takehiko, Zindy, Frederique, Roussel, Martine F., Quelle, Dawn E., Downing, James R., Ashmun, Richard A., Grosveld, Gerard, Sherr, Charles J.. Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19 ARF. Cell, vol.91, no.5, 649-659.
Klangby, Ulf, Okan, Ismail, Magnusson, Kristinn P., Wendland, Martin, Lind, Peter, Wiman, Klas G.. p16/INK4a and p15/INK4b Gene Methylation and Absence of p16/INK4a mRNA and Protein Expression in Burkitt's Lymphoma. Blood, vol.91, no.5, 1680-1687.
Koh, James, Enders, Greg H., David Dynlacht, Brian, Harlow, Ed. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature, vol.375, no.6531, 506-510.
Leukemia Kovalchuk A. L. 909 14 2000 10.1038/sj.leu.2401676
MacPhee, Melina, Chepenik, Kenneth P, Liddell, Rebecca A, Nelson, Kelly K, Siracusa, Linda D, Buchberg, Arthur M. The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia. Cell, vol.81, no.6, 957-966.
Curr. Top. Microbiol. Immunol. Mock B. 125 141 1988
Mock, Beverly A., Hartley, Janet, Le Tissier, Paul, Wax, Judith S., Potter, Michael. The Plasmacytoma Resistance Gene, Pctr2, Delays the Onset of Tumorigenesis and Resides in the Telomeric Region of Chromosome 4. Blood, vol.90, no.10, 4092-4098.
Mock, B A, Krall, M M, Dosik, J K. Genetic mapping of tumor susceptibility genes involved in mouse plasmacytomagenesis.. Proceedings of the National Academy of Sciences of the United States of America, vol.90, no.20, 9499-9503.
Neumann, Carola, Zehentmaier, Gundula, Danhauser‐Riedl, Susanne, Emmerich, Bertold, Hallek, Michael. Interleukin‐6 induces tyrosine phosphorylation of the Ras activating protein Shc, and its complex formation with Grb2 in the human multiple myeloma cell line LP‐1. European journal of immunology, vol.26, no.2, 379-384.
Cell Growth Differ. Nevins J. R. 585 9 1998
Ng, M.H.L., Chung, Y.F., Lo, K.W., Wickham, N.W.R., Lee, J.C.K., Huang, D.P.. Frequent Hypermethylation of p16 and p15 Genes in Multiple Myeloma. Blood, vol.89, no.7, 2500-2506.
Ogata, A, Chauhan, D, Teoh, G, Treon, S P, Urashima, M, Schlossman, R L, Anderson, K C. IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade.. The journal of immunology : official journal of the American Association of Immunologists, vol.159, no.5, 2212-2221.
Pomerantz, Jason, Schreiber-Agus, Nicole, Liégeois, Nanette J, Silverman, Adam, Alland, Leila, Chin, Lynda, Potes, Jason, Chen, Ken, Orlow, Irene, Lee, Han-Woong, Cordon-Cardo, Carlos, DePinho, Ronald A. The Ink4a Tumor Suppressor Gene Product, p19Arf, Interacts with MDM2 and Neutralizes MDM2's Inhibition of p53. Cell, vol.92, no.6, 713-723.
Cancer Res. Potter M. 969 54 1994
Potter, Michael, Robertson, Charlotte L.. Development of Plasma-Cell Neoplasms in BALB/c Mice After Intraperitoneal Injection of Paraffin-Oil Adjuvant, Heat-Killed Staphylococcus Mixtures. Journal of the National Cancer Institute: JNCI, vol.25, no.4, 847-861.
Quelle, Dawn E., Cheng, Mangeng, Ashmun, Richard A., Sherr, Charles J.. Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16 INK4a but not by the alternative reading frame protein p19 ARF. Proceedings of the National Academy of Sciences of the United States of America, vol.94, no.2, 669-673.
Ouelle, Dawn E., Zindy, Frédérique, Ashmun, Richard A., Sherr, Charles J.. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell, vol.83, no.6, 993-1000.
Quesnel, Bruno, Preudhomme, Claude, Fenaux, Pierre. p16ink4a Gene and Hematological Malignancies. Leukemia & lymphoma, vol.22, no.1, 11-24.
Robles, Ana I, Wang, Xin W, Harris, Curtis C. Drug-induced apoptosis is delayed and reduced in XPD lymphoblastoid cell lines: possible role of TFIIH in p53-mediated apoptotic cell death. Oncogene, vol.18, no.33, 4681-4688.
Molecular cloning: a laboratory manual Sambrook J. 1989 2
10.1182/blood.V94.2.748
Serrano, Manuel, Lee, Han-Woong, Chin, Lynda, Cordon-Cardo, Carlos, Beach, David, DePinho, Ronald A. Role of the INK4a Locus in Tumor Suppression and Cell Mortality. Cell, vol.85, no.1, 27-37.
Blood Shacter E. 194 80 1992 10.1182/blood.V80.1.194.194
Tanaka, Hiroshi, Arakawa, Hirofumi, Yamaguchi, Tatsuya, Shiraishi, Kenji, Fukuda, Seisuke, Matsui, Kuniko, Takei, Yoshiki, Nakamura, Yusuke. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature, vol.404, no.6773, 42-49.
Tao, Weikang, Levine, Arnold J.. P19 ARF stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2. Proceedings of the National Academy of Sciences of the United States of America, vol.96, no.12, 6937-6941.
Tasaka, Taizo, Berenson, James, Vescio, Robert, Hirama, Toshiyasu, Miller, Carl W., Nagai, Masami, Takahara, Jiro, Koeffler, H. Phillip. Analysis of the p16INK4A, p15INK4B and p18INK4C genes in multiple myeloma. British journal of haematology, vol.96, no.1, 98-102.
J. Med. Genet. Wallis Y. L. 14 36 1999
Weinberg, Robert A. The retinoblastoma protein and cell cycle control. Cell, vol.81, no.3, 323-330.
Cancer Res. Wiener F. 1181 55 1995
Mol. Cell. Biol. Willumsen B. M. 6026 9 1991
Zhang, Shuling, Ramsay, Edward S., Mock, Beverly A.. Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4aand p19ARF, is a candidate for the plasmacytoma susceptibility locus,Pctr1. Proceedings of the National Academy of Sciences of the United States of America, vol.95, no.5, 2429-2434.
Zhang, Yanping, Xiong, Yue. Mutations in Human ARF Exon 2 Disrupt Its Nucleolar Localization and Impair Its Ability to Block Nuclear Export of MDM2 and p53. Molecular cell, vol.3, no.5, 579-591.
Zhang, Yanping, Xiong, Yue, Yarbrough, Wendell G. ARF Promotes MDM2 Degradation and Stabilizes p53: ARF-INK4a Locus Deletion Impairs Both the Rb and p53 Tumor Suppression Pathways. Cell, vol.92, no.6, 725-734.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.